日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallenge.

表观遗传疗法可使对PD-1抗体耐药的头颈癌对免疫疗法再次治疗敏感

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI181671
Qin Tingting, Mattox Austin K, Campbell Jean S, Park Jong Chul, Shin Kee-Young, Li Shiting, Sadow Peter M, Faquin William C, Micevic Goran, Daniels Andrew J, Haddad Robert, Garris Christopher S, Pittet Mikael J, Mempel Thorsten R, ONeill Anne, Sartor Maureen A, Pai Sara I
表观遗传
发表日期：2025
文献求助 收藏

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108

单药他莫昔芬治疗转移性乳腺癌患者的CYP2D6活性：ECOG-ACRIN E3108研究结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-024-07519-z
Stearns, Vered; ONeill, Anne; Schneider, Bryan P; Skaar, Todd C; Liu, Minetta C; Lohrisch, Caroline; Goetz, Matthew P; Vallejos, Carlos S; Sparano, Joseph A; Villa, Diego; Silverman, Paula; Cheema, Puneet S; Moore, Dennis F Jr; Sledge, George W Jr
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial

纳武利尤单抗治疗高危口腔白斑患者：一项非随机对照试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.4853
Hanna, Glenn J; Villa, Alessandro; Nandi, Shuvro P; Shi, Ruichao; ONeill, Anne; Liu, Mofei; Quinn, Charles T; Treister, Nathaniel S; Sroussi, Herve Y; Vacharotayangul, Piamkamon; Goguen, Laura A; Annino, Donald J Jr; Rettig, Eleni M; Jo, Vickie Y; Wong, Kristine S; Lizotte, Patrick; Paweletz, Cloud P; Uppaluri, Ravindra; Haddad, Robert I; Cohen, Ezra E W; Alexandrov, Ludmil B; William, William N Jr; Lippman, Scott M; Woo, Sook-Bin
发表日期：2024
文献求助 收藏

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

一项针对 HER2/neu 阳性转移性乳腺癌患者的一线化疗联合曲妥珠单抗（有或无贝伐珠单抗）的随机 III 期双盲安慰剂对照试验：ECOG-ACRIN 癌症研究组 (E1105) 的一项试验

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-024-07417-4
Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A; Arteaga, Carlos L; Yang, Ximing J; Wagner, Lynne I; Cella, David; Meropol, Neal J; Alpaugh, R Katherine; Saphner, Thomas J; Swaney, Robert E; Hoelzer, Karen L; Gradishar, William J; Abramson, Vandana G; Sundaram, P Kothai; Jilani, Shamim Z; Perez, Edith A; Lin, Nancy U; Jahanzeb, Mohammad; Wolff, Antonio C; Sledge, George W; Reid, Sonya A
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

一项针对 HER2/neu 阳性转移性乳腺癌患者的一线化疗联合曲妥珠单抗（有或无贝伐珠单抗）的随机 III 期双盲安慰剂对照试验：ECOG-ACRIN 癌症研究组的一项试验 (E1105)

期刊:
影响因子:
doi:10.21203/rs.3.rs-4295044/v1
Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A; Arteaga, Carlos L; Yang, Ximing J; Wagner, Lynne I; Cella, David; Meropol, Neal J; Alpaugh, R Katherine; Saphner, Thomas J; Swaney, Robert E; Hoelzer, Karen L; Gradishar, William J; Abramson, Vandana G; Sundaram, P Kothai; Jilani, Shamim Z; Perez, Edith A; Lin, Nancy U; Jahanzeb, Mohammad; Wolff, Antonio C; Sledge, George W; Reid, Sonya A
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805

ECOG-ACRIN E2805研究中青少年/青年血管内皮生长因子抑制的心血管影响

期刊:Journal of the National Comprehensive Cancer Network
影响因子:16.4
doi:10.6004/jnccn.2023.7018
Bottinor, Wendy J; Flamand, Yael; Haas, Naomi B; ONeill, Anne M; DiPaola, Robert S; Subramanian, Pearl; Cella, David; Hundley, W Gregory; Wagner, Lynne I; Salsman, John M; Ky, Bonnie
心血管
发表日期：2023
文献求助 收藏